Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Askling

Showing results (111-120 of 345) with videos related to

Pageof 35
Sort By:
BMJ (Clinical Research Ed.)|May 17, 2003
Perinatal characteristics and risk of rheumatoid arthritisLennart T H Jacobsson, Magnus E Jacobsson, Johan Askling, et al.
Annals of the Rheumatic Diseases|January 17, 2014
Effectiveness of TNF inhibitor switch in RA: results from the national Swedish registerKaterina Chatzidionysiou, Johan Askling, Jonas Eriksson, et al.
Respiratory Medicine|May 21, 2019
Correspondence for "Clinical epidemiology of familial sarcoidosis: A systematic literature review"Marios Rossides, Johan Grunewald, Anders Eklund, et al.
Arthritis Research & Therapy|August 6, 2022
Does persistence to methotrexate treatment in early rheumatoid arthritis have a familial component?Anton Öberg Sysojev, Thomas Frisell, Bénédicte Delcoigne, et al.
Acta Oncologica (Stockholm, Sweden)|July 13, 2004
Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphomaEva Osby, Johan Askling, Ola Landgren, et al.
Annals of the Rheumatic Diseases|September 23, 2022
Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritisViktor Molander, Hannah Bower, Thomas Frisell, et al.
Gastroenterology|October 31, 2002
Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformisJohan Askling, Martha Linet, Gloria Gridley, et al.
Annals of the Rheumatic Diseases|March 11, 2014
Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?Elizabeth V Arkema, Jerker Jonsson, Eva Baecklund, et al.
Rheumatology (Oxford, England)|January 23, 2019
Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish registerThomas Frisell, Mats Dehlin, Daniela Di Giuseppe, et al.
Arthritis Care & Research|December 7, 2020
Findings on Coronary Angiographies in Patients With Rheumatoid Arthritis and Ischemic Heart Disease: Are They Different From Patients Without Rheumatoid Arthritis?Marie Holmqvist, Ängla Mantel, Solveig Wållberg-Jonsson, et al.
Pageof 35

Showing results (111-120 of 345) with videos related to

Sort By:
Pageof 35
BMJ (Clinical Research Ed.)|May 17, 2003
Perinatal characteristics and risk of rheumatoid arthritisLennart T H Jacobsson, Magnus E Jacobsson, Johan Askling, et al.
Annals of the Rheumatic Diseases|January 17, 2014
Effectiveness of TNF inhibitor switch in RA: results from the national Swedish registerKaterina Chatzidionysiou, Johan Askling, Jonas Eriksson, et al.
Respiratory Medicine|May 21, 2019
Correspondence for "Clinical epidemiology of familial sarcoidosis: A systematic literature review"Marios Rossides, Johan Grunewald, Anders Eklund, et al.
Arthritis Research & Therapy|August 6, 2022
Does persistence to methotrexate treatment in early rheumatoid arthritis have a familial component?Anton Öberg Sysojev, Thomas Frisell, Bénédicte Delcoigne, et al.
Acta Oncologica (Stockholm, Sweden)|July 13, 2004
Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphomaEva Osby, Johan Askling, Ola Landgren, et al.
Annals of the Rheumatic Diseases|September 23, 2022
Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritisViktor Molander, Hannah Bower, Thomas Frisell, et al.
Gastroenterology|October 31, 2002
Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformisJohan Askling, Martha Linet, Gloria Gridley, et al.
Annals of the Rheumatic Diseases|March 11, 2014
Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?Elizabeth V Arkema, Jerker Jonsson, Eva Baecklund, et al.
Rheumatology (Oxford, England)|January 23, 2019
Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish registerThomas Frisell, Mats Dehlin, Daniela Di Giuseppe, et al.
Arthritis Care & Research|December 7, 2020
Findings on Coronary Angiographies in Patients With Rheumatoid Arthritis and Ischemic Heart Disease: Are They Different From Patients Without Rheumatoid Arthritis?Marie Holmqvist, Ängla Mantel, Solveig Wållberg-Jonsson, et al.
Pageof 35